To keep research teams informed of the latest updates to ClinicalTrials.gov, the University at Buffalo Clinical and Translational Science Institute (CTSI) will be providing news about the ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

The Advanced Research Projects Agency for Health, an agency within the U.S. Department of Health and Human Services, published a new program on January 13, 2026, with an ambitious target: building the ...

Key opportunities include expanding cloud-based platforms, leveraging interventional and oncology trials, targeting ...

CTSI Watch and Learn educational module videos are designed to increase the knowledge and performance of clinical researchers at UB and its affiliated institutions. These 5- to 15-minute videos offer ...

New DLBCL trials test bispecifics with chemo, BTK add-ons, and MRD-guided preemptive allo CAR-T to cut relapse risk. The ...

"Non-Small Cell Lung Cancer Clinical Trial"Major NSCLC companies include BridgeBio Pharma, Daiichi Sankyo, EMD Serono/Merck, AbbVie/Pfizer, Eli Lilly and Company, BioNTech SE, Shenzhen TargetRx, Taiho ...

CNSide Diagnostics will present data from the FORESEE trial showcasing the CNSide CSF Assay Platform’s utility in diagnosing and guiding clinical decision making for breast cancer and non-small cell ...

Thomas Laughren, director of the Food and Drug Administration’s (FDA’s) Division of Psychiatry Products, explained the FDA’s current policies and recommendations surrounding the relationship between ...

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIASARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...